獣医腫瘍診断薬の市場規模、シェア、動向分析レポート：動物の種類別、検査タイプ別、がんの種類別、最終用途別、地域別、セグメント予測、2025年～2030年

獣医腫瘍診断市場の成長と動向：

Grand View Research, Inc.の最新レポートによると、世界の獣医がん診断市場は2025年から2030年にかけてCAGR 8.4％を記録し、2030年までに34億5,000万米ドルに達すると予測されています。

この市場は主に、動物人口と飼育率の増加、動物への支出の増加、予防的動物ヘルスケアへの重点の移行、獣医がん診断検査の進歩、革新的な製品を発売するための動物健康診断への研究開発投資の増加によって牽引されています。例えば、2024年12月、Pet Preferred Diagnostics社は、21種類の腫瘍と14種類の神経疾患に関連する11種類の特異的な腫瘍性抗体を検出する犬猫用の画期的な早期がん診断検査を発表しました。この高感度血清学的検査は、多くの場合、臨床症状が現れる前に悪性腫瘍を特定し、早期治療を可能にします。この検査は、様々な腫瘍と神経疾患を鑑別する獣医学で利用可能な唯一の検査であり、非侵襲的で、手頃な価格で、24時間以内に結果が出る迅速なソリューションを提供します。

さらに、Oncotectによる世界初で唯一の家庭用がんスクリーニング検査など、先進的な獣医がん診断検査の開発が、獣医がん診断市場に有利な機会を生み出しています。この革新的な犬がんスクリーニング検査は早期発見を可能にし、治療成績を向上させ、飼い主に安心感を与えます。最も一般的な4種類の犬がんを検出するOncotectは、自宅でも診療所でも使用できるため、ユーザーフレンドリーで利用しやすいです。家庭での検査ソリューションの増加は、その正確性を裏付ける臨床データと相まって、特にペットの飼い主が利用しやすくなることで、獣医がん診断市場を拡大しています。

さらに、ペットのがん罹患率の増加が、獣医がん診断市場の成長を大きく後押ししています。The Veterinary Cancer Society（獣医がん協会）によると、がんはイヌ、特に10歳以上のイヌの47%、ネコの32%の死亡原因のトップです。犬の約4頭に1頭は、一生の間に組織の異常増殖、つまり新形成を経験します。ペットには100種類近いがんが存在するため、診断に圧倒されることもありますが、獣医療の進歩により、犬も猫も治療の成功率は向上しています。オーストラリア研究データコモンズ（ARDC）の2024年5月の調査によると、オーストラリアでは犬の4匹に1匹、猫の5匹に1匹が罹患しています。米国では、2024年に約600万頭の愛犬ががんと診断されると予想されており、ペットと人間の両方のがん診断を改善するまたとない機会が生まれている、とThe Cancer Letter Inc.が報告しています。さらに、米国獣医師会は、4頭に1頭の犬がいずれ新生物を発症し、10歳以上の犬の約半数ががんを発症すると述べています。

獣医がん診断市場レポートハイライト

• 検査タイプ別では、生検分野が2024年に32.08%のシェアで市場を独占しました。しかし、ゲノム検査分野は、獣医がん診断検査キットの技術的進歩により、予測期間中にCAGR 9.48%の最速成長が見込まれます。
• 動物タイプ別では、イヌのがん人口の増加とイヌのがん診断のための膨大な数の製品が利用可能であることから、イヌのセグメントが2024年に最大の市場シェアを占めます。ネコのセグメントは、世界のネコの人口増加と関連疾患の明らかな増加により、2025年から2030年にかけて最も速い速度で成長すると予測されています。
• がんの種類別では、皮膚がんセグメントが2024年に最も高い市場シェアを占め、犬猫における扁平上皮がんと皮膚腫瘍の有病率の上昇により、CAGR 8.56%の最速成長が予測されています。
• 最終用途別では、動物病院・クリニック分野が2024年に市場で最も高いシェアを占めましたが、これは診断に対する需要が増加していることと、病院で容易に利用できる高度な獣医がん診断技術があるためです。このセグメントは、今後数年間で最も速いCAGRで成長すると推定されています。
• 地域別では、北米が2024年に53.9%と最大のシェアを占め、今後数年間で8.6%と最も急成長すると予測されています。
• 革新的なリキッドバイオプシーと先進的なマルチがん診断技術の開発により、より正確で使い勝手が良く、費用対効果の高い獣医がん診断検査キットが開発されています。このような進歩は市場の成長を促進すると予想されます。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 獣医腫瘍診断市場の変動動向と範囲

• 市場系統の見通し
  • 親市場
  • 補助市場
• 市場力学
  • 市場ドライバー分析
  • 市場抑制要因分析
  • 市場機会分析
  • 市場課題分析
• 獣医腫瘍診断市場分析ツール
  • 業界分析- ポーターのファイブフォース分析
  • PESTEL分析
  • 規制の枠組み
  • 主要国および主要種別の動物の推定個体数（2018～2024年）
  • COVID-19の影響分析

第4章 獣医腫瘍診断市場：動物の種類推定・動向分析

• セグメントダッシュボード
• 獣医腫瘍診断市場動物の種類の変動分析
• 獣医腫瘍診断市場の規模と動向分析、動物の種類別、2018～2030年
  • 犬
  • 猫
  • その他

第5章 獣医腫瘍診断市場： 検査タイプの推定・動向分析

• セグメントダッシュボード
• 獣医腫瘍診断市場検査タイプの変動分析
• 獣医腫瘍診断市場の規模と動向分析、検査タイプ別、2018～2030年
  • 血液検査
  • 生検
  • ゲノム検査
  • 内視鏡検査
  • 尿検査
  • イメージング

第6章 獣医腫瘍診断市場：がんの種類の推定・動向分析

• セグメントダッシュボード
• 獣医腫瘍診断市場がんの種類の変動分析
• 獣医腫瘍診断市場の規模と動向分析、がんの種類別、2018～2030年
  • リンパ腫
  • 肉腫
  • 乳腺腫瘍
  • 皮膚がん
  • その他

第7章 獣医腫瘍診断市場：最終用途の推定・動向分析

• セグメントダッシュボード
• 獣医腫瘍診断市場の最終用途の変動分析
• 獣医腫瘍診断市場の規模と動向分析、最終用途別、2018～2030年
  • リファレンスラボ
  • 動物病院および診療所

第8章 獣医腫瘍診断市場：国推定・動向分析

• 地域ダッシュボード
• 獣医腫瘍診断市場シェア、地域別、2023年および2030年
• 地域展望
• 北米
  • 米国
  • メキシコ
• 欧州
  • 英国
  • ドイツ
  • フランス
  • イタリア
  • スペイン
  • デンマーク
  • スウェーデン
  • ノルウェー
• アジア太平洋
  • 日本
  • 中国
  • インド
  • オーストラリア
  • 韓国
  • タイ
• ラテンアメリカ
  • ブラジル
  • アルゼンチン
• 中東・アフリカ
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦
  • クウェート

第9章 競合情勢

• 市場参入企業の分類
• Participants Overview
• 財務実績
• 製品ベンチマーク
• 市況分析、2024年（ヒートマップ分析）
• 戦略マッピング
  • 合併と買収
  • 立ち上げ
  • パートナーシップとコラボレーション
  • 拡大
  • その他
• 企業プロファイル
  • Zoetis
  • Antech Diagnostics, Inc.（Mars Inc.）
  • IDEXX Laboratories, Inc.
  • Neogen Corporation
  • Gold Standard Diagnostics（Eurofins Technologies）
  • Embark Veterinary, Inc.
  • VolitionRx Limited
  • CANCAN DIAGNOSTICS
  • Oncotect
  • PetDx
• List of Other Market Players

第10章 重要なポイント

List of Tables

• Tables 1 List of Secondary Sources
• Tables 2 List of Abbreviations
• Tables 3 Global Veterinary Oncology Diagnostics Market, by Animal, 2018 - 2030 (USD Million)
• Tables 4 Global Veterinary Oncology Diagnostics Market, by Test Type, 2018 - 2030 (USD Million)
• Tables 5 Global Veterinary Oncology Diagnostics Market, by Cancer Type, 2018 - 2030 (USD Million)
• Tables 6 Global Veterinary Oncology Diagnostics Market, by End-Use, 2018 - 2030 (USD Million)
• Tables 7 North America Veterinary Oncology Diagnostics Market, by country, 2018 - 2030 (USD
• Tables 8 North America Veterinary Oncology Diagnostics Market, by Animal, 2018 - 2030 (USD Million)
• Tables 9 North America Veterinary Oncology Diagnostics Market, by Test Type, 2018 - 2030 (USD Million)
• Tables 10 North America Veterinary Oncology Diagnostics Market, by Cancer Type, 2018 - 2030 (USD Million)
• Tables 11 North America Veterinary Oncology Diagnostics Market, by End-Use, 2018 - 2030 (USD Million)
• Tables 12 U.S Veterinary Oncology Diagnostics Market, by Animal, 2018 - 2030 (USD Million)
• Tables 13 U.S Veterinary Oncology Diagnostics Market, by Test Type, 2018 - 2030 (USD Million)
• Tables 14 U.S Veterinary Oncology Diagnostics Market, by Cancer Type, 2018 - 2030 (USD Million)
• Tables 15 U.S Veterinary Oncology Diagnostics Market, by End-Use, 2018 - 2030 (USD Million)
• Tables 16 Canada Veterinary Oncology Diagnostics Market, by Animal, 2018 - 2030 (USD Million)
• Tables 17 Canada Veterinary Oncology Diagnostics Market, by Test Type, 2018 - 2030 (USD Million)
• Tables 18 Canada Veterinary Oncology Diagnostics Market, by Cancer Type, 2018 - 2030 (USD Million)
• Tables 19 Canada Veterinary Oncology Diagnostics Market, by End-Use, 2018 - 2030 (USD Million)
• Tables 20 Mexico Veterinary Oncology Diagnostics Market, by Animal, 2018 - 2030 (USD Million)
• Tables 21 Mexico Veterinary Oncology Diagnostics Market, by Test Type, 2018 - 2030 (USD Million)
• Tables 22 Mexico Veterinary Oncology Diagnostics Market, by Cancer Type, 2018 - 2030 (USD Million)
• Tables 23 Mexico Veterinary Oncology Diagnostics Market, by End-Use, 2018 - 2030 (USD Million)
• Tables 24 Europe Veterinary Oncology Diagnostics Market, by country, 2018 - 2030 (USD Million)
• Tables 25 Europe Veterinary Oncology Diagnostics Market, by Test Type, 2018 - 2030 (USD Million)
• Tables 26 Europe Veterinary Oncology Diagnostics Market, by animal type, 2018 - 2030 (USD Million)
• Tables 27 Europe Veterinary Oncology Diagnostics Market, by cancer type, 2018 - 2030 (USD Million)
• Tables 28 Europe Veterinary Oncology Diagnostics Market, by End-Use, 2018 - 2030 (USD Million)
• Tables 29 Germany Veterinary Oncology Diagnostics Market, by Test Type, 2018 - 2030 (USD Million)
• Tables 30 Germany Veterinary Oncology Diagnostics Market, by animal type, 2018 - 2030 (USD Million)
• Tables 31 Germany Veterinary Oncology Diagnostics Market, by cancer type, 2018 - 2030 (USD Million)
• Tables 32 Germany Veterinary Oncology Diagnostics Market, by End-Use, 2018 - 2030 (USD Million)
• Tables 33 U.K Veterinary Oncology Diagnostics Market, by Test Type, 2018 - 2030 (USD Million)
• Tables 34 U.K Veterinary Oncology Diagnostics Market, by animal type, 2018 - 2030 (USD Million)
• Tables 35 UK Veterinary Oncology Diagnostics Market, by cancer type, 2018 - 2030 (USD Million)
• Tables 36 UK Veterinary Oncology Diagnostics Market, by End-Use, 2018 - 2030 (USD Million)
• Tables 37 France Veterinary Oncology Diagnostics Market, by Test Type, 2018 - 2030 (USD Million)
• Tables 38 France Veterinary Oncology Diagnostics Market, by animal type, 2018 - 2030 (USD Million)
• Tables 39 France Veterinary Oncology Diagnostics Market, by cancer type, 2018 - 2030 (USD Million)
• Tables 40 France Veterinary Oncology Diagnostics Market, by End-Use, 2018 - 2030 (USD Million)
• Tables 41 Italy Veterinary Oncology Diagnostics Market, by Test Type, 2018 - 2030 (USD Million)
• Tables 42 Italy Veterinary Oncology Diagnostics Market, by animal type, 2018 - 2030 (USD Million)
• Tables 43 Italy Veterinary Oncology Diagnostics Market, by cancer type, 2018 - 2030 (USD Million)
• Tables 44 Italy Veterinary Oncology Diagnostics Market, by End-Use, 2018 - 2030 (USD Million)
• Tables 45 Spain Veterinary Oncology Diagnostics Market, by Test Type, 2018 - 2030 (USD Million)
• Tables 46 Spain Veterinary Oncology Diagnostics Market, by animal type, 2018 - 2030 (USD Million)
• Tables 47 Spain Veterinary Oncology Diagnostics Market, by cancer type, 2018 - 2030 (USD Million)
• Tables 48 Spain Veterinary Oncology Diagnostics Market, by End-Use, 2018 - 2030 (USD Million)
• Tables 49 Sweden Veterinary Oncology Diagnostics Market, by Test Type, 2018 - 2030 (USD Million)
• Tables 50 Sweden Veterinary Oncology Diagnostics Market, by animal type, 2018 - 2030 (USD Million)
• Tables 51 Sweden Veterinary Oncology Diagnostics Market, by cancer type, 2018 - 2030 (USD Million)
• Tables 52 Sweden Veterinary Oncology Diagnostics Market, by End-Use, 2018 - 2030 (USD Million)
• Tables 53 Denmark Veterinary Oncology Diagnostics Market, by Test Type, 2018 - 2030 (USD Million)
• Tables 54 Denmark Veterinary Oncology Diagnostics Market, by animal type, 2018 - 2030 (USD Million)
• Tables 55 Denmark Veterinary Oncology Diagnostics Market, by cancer type, 2018 - 2030 (USD Million)
• Tables 56 Denmark Veterinary Oncology Diagnostics Market, by End-Use, 2018 - 2030 (USD Million)
• Tables 57 Norway Veterinary Oncology Diagnostics Market, by Test Type, 2018 - 2030 (USD Million)
• Tables 58 Norway Veterinary Oncology Diagnostics Market, by animal type, 2018 - 2030 (USD Million)
• Tables 59 Norway Veterinary Oncology Diagnostics Market, by cancer type, 2018 - 2030 (USD Million)
• Tables 60 Norway Veterinary Oncology Diagnostics Market, by End-Use, 2018 - 2030 (USD Million)
• Tables 61 Asia Pacific Veterinary Oncology Diagnostics Market, by country, 2018 - 2030 (USD Million)
• Tables 62 Asia Pacific Veterinary Oncology Diagnostics Market, by Test Type, 2018 - 2030 (USD Million)
• Tables 63 Asia Pacific Veterinary Oncology Diagnostics Market, by animal type, 2018 - 2030 (USD Million)
• Tables 64 Asia Pacific Veterinary Oncology Diagnostics Market, by cancer type, 2018 - 2030 (USD Million)
• Tables 65 Asia Pacific Veterinary Oncology Diagnostics Market, by End-Use, 2018 - 2030 (USD Million)
• Tables 66 Japan Veterinary Oncology Diagnostics Market, by Test Type, 2018 - 2030 (USD Million)
• Tables 67 Japan Veterinary Oncology Diagnostics Market, by animal type, 2018 - 2030 (USD Million)
• Tables 68 Japan Veterinary Oncology Diagnostics Market, by cancer type, 2018 - 2030 (USD Million)
• Tables 69 Japan Veterinary Oncology Diagnostics Market, by End-Use, 2018 - 2030 (USD Million)
• Tables 70 China Veterinary Oncology Diagnostics Market, by Test Type, 2018 - 2030 (USD Million)
• Tables 71 China Veterinary Oncology Diagnostics Market, by animal type, 2018 - 2030 (USD Million)
• Tables 72 China Veterinary Oncology Diagnostics Market, by cancer type, 2018 - 2030 (USD Million)
• Tables 73 China Veterinary Oncology Diagnostics Market, by End-Use, 2018 - 2030 (USD Million)
• Tables 74 India Veterinary Oncology Diagnostics Market, by Test Type, 2018 - 2030 (USD Million)
• Tables 75 India Veterinary Oncology Diagnostics Market, by animal type, 2018 - 2030 (USD Million)
• Tables 76 India Veterinary Oncology Diagnostics Market, by cancer type, 2018 - 2030 (USD Million)
• Tables 77 India Veterinary Oncology Diagnostics Market, by End-Use, 2018 - 2030 (USD Million)
• Tables 78 Australia Veterinary Oncology Diagnostics Market, by Test Type, 2018 - 2030 (USD Million)
• Tables 79 Australia Veterinary Oncology Diagnostics Market, by animal type, 2018 - 2030 (USD Million)
• Tables 80 Australia Veterinary Oncology Diagnostics Market, by cancer type, 2018 - 2030 (USD Million)
• Tables 81 Australia Veterinary Oncology Diagnostics Market, by End-Use, 2018 - 2030 (USD Million)
• Tables 82 South Korea Veterinary Oncology Diagnostics Market, by Test Type, 2018 - 2030 (USD Million)
• Tables 83 South Korea Veterinary Oncology Diagnostics Market, by animal type, 2018 - 2030 (USD Million)
• Tables 84 South Korea Veterinary Oncology Diagnostics Market, by cancer type, 2018 - 2030 (USD Million)
• Tables 85 South Korea Veterinary Oncology Diagnostics Market, by End-Use, 2018 - 2030 (USD Million)
• Tables 86 Thailand Veterinary Oncology Diagnostics Market, by Test Type, 2018 - 2030 (USD Million)
• Tables 87 Thailand Veterinary Oncology Diagnostics Market, by animal type, 2018 - 2030 (USD Million)
• Tables 88 Thailand Veterinary Oncology Diagnostics Market, by cancer type, 2018 - 2030 (USD Million)
• Tables 89 Thailand Veterinary Oncology Diagnostics Market, by End-Use, 2018 - 2030 (USD Million)
• Tables 90 LATAM Veterinary Oncology Diagnostics Market, by country, 2018 - 2030 (USD Million)
• Tables 91 LATAM Veterinary Oncology Diagnostics Market, by Test Type, 2018 - 2030 (USD Million)
• Tables 92 LATAM Veterinary Oncology Diagnostics Market, by animal type, 2018 - 2030 (USD Million)
• Tables 93 LATAM Veterinary Oncology Diagnostics Market, by cancer type, 2018 - 2030 (USD Million)
• Tables 94 LATAM Veterinary Oncology Diagnostics Market, by End-Use, 2018 - 2030 (USD Million)
• Tables 95 Brazil Veterinary Oncology Diagnostics Market, by Test Type, 2018 - 2030 (USD Million)
• Tables 96 Brazil Veterinary Oncology Diagnostics Market, by animal type, 2018 - 2030 (USD Million)
• Tables 97 Brazil Veterinary Oncology Diagnostics Market, by cancer type, 2018 - 2030 (USD Million)
• Tables 98 Brazil Veterinary Oncology Diagnostics Market, by End-Use, 2018 - 2030 (USD Million)
• Tables 99 Argentina Veterinary Oncology Diagnostics Market, by Test Type, 2018 - 2030 (USD Million)
• Tables 100 Argentina Veterinary Oncology Diagnostics Market, by animal type, 2018 - 2030 (USD Million)
• Tables 101 Argentina Veterinary Oncology Diagnostics Market, by cancer type, 2018 - 2030 (USD Million)
• Tables 102 Argentina Veterinary Oncology Diagnostics Market, by End-Use, 2018 - 2030 (USD Million)
• Tables 103 MEA Veterinary Oncology Diagnostics Market, by country, 2018 - 2030 (USD Million)
• Tables 104 MEA Veterinary Oncology Diagnostics Market, by Test Type, 2018 - 2030 (USD Million)
• Tables 105 MEA Veterinary Oncology Diagnostics Market, by animal type, 2018 - 2030 (USD Million)
• Tables 106 MEA Veterinary Oncology Diagnostics Market, by cancer type, 2018 - 2030 (USD Million)
• Tables 107 MEA Veterinary Oncology Diagnostics Market, by End-Use, 2018 - 2030 (USD Million)
• Tables 108 South Africa Veterinary Oncology Diagnostics Market, by Test Type, 2018 - 2030 (USD Million)
• Tables 109 South Africa Veterinary Oncology Diagnostics Market, by animal type, 2018 - 2030 (USD Million)
• Tables 110 South Africa Veterinary Oncology Diagnostics Market, by cancer type, 2018 - 2030 (USD Million)
• Tables 111 South Africa Veterinary Oncology Diagnostics Market, by End-Use, 2018 - 2030 (USD Million)
• Tables 112 Saudi Arabia Veterinary Oncology Diagnostics Market, by Test Type, 2018 - 2030 (USD Million)
• Tables 113 Saudi Arabia Veterinary Oncology Diagnostics Market, by animal type, 2018 - 2030 (USD Million)
• Tables 114 Saudi Arabia Veterinary Oncology Diagnostics Market, by cancer type, 2018 - 2030 (USD Million)
• Tables 115 Saudi Arabia Veterinary Oncology Diagnostics Market, by End-Use, 2018 - 2030 (USD Million)
• Tables 116 UAE Veterinary Oncology Diagnostics Market, by Test Type, 2018 - 2030 (USD Million)
• Tables 117 UAE Veterinary Oncology Diagnostics Market, by animal type, 2018 - 2030 (USD Million)
• Tables 118 UAE Veterinary Oncology Diagnostics Market, by cancer type, 2018 - 2030 (USD Million)
• Tables 119 UAE Veterinary Oncology Diagnostics Market, by End-Use, 2018 - 2030 (USD Million)
• Tables 120 Kuwait Veterinary Oncology Diagnostics Market, by Test Type, 2018 - 2030 (USD Million)
• Tables 121 Kuwait Veterinary Oncology Diagnostics Market, by animal type, 2018 - 2030 (USD Million)
• Tables 122 Kuwait Veterinary Oncology Diagnostics Market, by cancer type, 2018 - 2030 (USD Million)
• Tables 123 Kuwait Veterinary Oncology Diagnostics Market, by End-Use, 2018 - 2030 (USD Million)
• Tables 124 Company Overview
• Tables 125 Service Benchmarking
• Tables 126 Financial Performance
• Tables 127 Strategic Initiatives

List of Figures

• Fig. 1 Global Veterinary Oncology Diagnostics Market segmentation
• Fig. 2 Market research process
• Fig. 3 Information procurement
• Fig. 4 Primary research pattern
• Fig. 5 Data Analysis Models
• Fig. 6 Market Formulation And Validation
• Fig. 7 Data Validating & Publishing
• Fig. 8 General methodology for a commodity flow analysis of Global Veterinary Oncology Diagnostics Market
• Fig. 9 Commodity flow analysis
• Fig. 10 Parent market analysis
• Fig. 11 Market snapshot
• Fig. 12 Segment snapshot
• Fig. 13 Segment snapshot
• Fig. 14 Competitive landscape snapshot
• Fig. 15 Parent market value, 2024 (USD Billion)
• Fig. 16 Ancillary market outlook, 2024
• Fig. 17 Global Veterinary Oncology Diagnostics Market Dynamics
• Fig. 18 Estimated animal population, 2018-2024 by key species and key countries
• Fig. 19 Global Veterinary Oncology Diagnostics Market: PORTER's analysis
• Fig. 20 Global Veterinary Oncology Diagnostics Market: PESTEL analysis
• Fig. 21 Global Veterinary Oncology Diagnostics Market by Animal: Key Takeaways
• Fig. 22 Global Veterinary Oncology Diagnostics Market by Animal, 2024 & 2030
• Fig. 23 Canine market, 2018 - 2030 (USD Million)
• Fig. 24 Feline market, 2018 - 2030 (USD Million)
• Fig. 25 Others market, 2018 - 2030 (USD Million)
• Fig. 26 Global Veterinary Oncology Diagnostics Market by Test Type: Key Takeaways
• Fig. 27 Global Veterinary Oncology Diagnostics Market by Test Type, Market Share, 2024 & 2030
• Fig. 28 Blood Tests market, 2018 - 2030 (USD Million)
• Fig. 29 Biopsy market, 2018 - 2030 (USD Million)
• Fig. 30 Genome testing market, 2018 - 2030 (USD Million)
• Fig. 31 Endoscopy market, 2018 - 2030 (USD Million)
• Fig. 32 Urinalysis market, 2018 - 2030 (USD Million)
• Fig. 33 Imaging market, 2018 - 2030 (USD Million)
• Fig. 34 Global Veterinary Oncology Diagnostics Market by Cancer Type: Key Takeaways
• Fig. 35 Global Veterinary Oncology Diagnostics Market by Cancer Type, Market Share, 2024 & 2030
• Fig. 36 Lymphoma market, 2018 - 2030 (USD Million)
• Fig. 37 Sarcomas market, 2018 - 2030 (USD Million)
• Fig. 38 Mammary Gland Tumors market, 2018 - 2030 (USD Million)
• Fig. 39 Skin Cancers market, 2018 - 2030 (USD Million)
• Fig. 40 Others market, 2018 - 2030 (USD Million)
• Fig. 41 Global Veterinary Oncology Diagnostics Market by End-Use: Key Takeaways
• Fig. 42 Global Veterinary Oncology Diagnostics Market by End-Use, Market Share, 2024 & 2030
• Fig. 43 Reference Laboratories market, 2018 - 2030 (USD Million)
• Fig. 44 Veterinary hospitals and clinics market, 2018 - 2030 (USD Million)
• Fig. 45 Regional market share analysis, 2024 & 2030
• Fig. 46 Regional marketplace: Key takeaways
• Fig. 47 North America Veterinary Oncology Diagnostics Market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 48 Key country dynamics
• Fig. 49 U.S Veterinary Oncology Diagnostics Market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 50 Key country dynamics
• Fig. 51 Canada Veterinary Oncology Diagnostics Market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 52 Key country dynamics
• Fig. 53 Mexico Veterinary Oncology Diagnostics Market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 54 Europe Veterinary Oncology Diagnostics Market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 55 Key country dynamics
• Fig. 56 UK Veterinary Oncology Diagnostics Market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 57 Key country dynamics
• Fig. 58 Germany Veterinary Oncology Diagnostics Market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 59 Key country dynamics
• Fig. 60 France Veterinary Oncology Diagnostics Market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 61 Key country dynamics
• Fig. 62 Italy Veterinary Oncology Diagnostics Market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 63 Key country dynamics
• Fig. 64 Spain Veterinary Oncology Diagnostics Market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 65 Key country dynamics
• Fig. 66 Sweden Veterinary Oncology Diagnostics Market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 67 Key country dynamics
• Fig. 68 Denmark Veterinary Oncology Diagnostics Market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 69 Key country dynamics
• Fig. 70 Norway Veterinary Oncology Diagnostics Market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 71 Asia Pacific Veterinary Oncology Diagnostics Market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 72 Key country dynamics
• Fig. 73 Japan Veterinary Oncology Diagnostics Market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 74 Key country dynamics
• Fig. 75 China Veterinary Oncology Diagnostics Market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 76 Key country dynamics
• Fig. 77 India Veterinary Oncology Diagnostics Market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 78 Key country dynamics
• Fig. 79 Australia Veterinary Oncology Diagnostics Market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 80 Key country dynamics
• Fig. 81 South Korea Veterinary Oncology Diagnostics Market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 82 Key country dynamics
• Fig. 83 Thailand Veterinary Oncology Diagnostics Market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 84 Latin America Veterinary Oncology Diagnostics Market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 85 Key country dynamics
• Fig. 86 Brazil Veterinary Oncology Diagnostics Market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 87 Key country dynamics
• Fig. 88 Argentina Veterinary Oncology Diagnostics Market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 89 Middle East and Africa Veterinary Oncology Diagnostics Market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 90 Key country dynamics
• Fig. 91 South Africa Veterinary Oncology Diagnostics Market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 92 Key country dynamics
• Fig. 93 Saudi Arabia Veterinary Oncology Diagnostics Market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 94 Key country dynamics
• Fig. 95 UAE Veterinary Oncology Diagnostics Market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 96 Key country dynamics
• Fig. 97 Kuwait Veterinary Oncology Diagnostics Market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 98 Market Participant Categorization
• Fig. 99 Heat map analysis
• Fig. 100 Strategic Framework

Veterinary Oncology Diagnostics Market Growth & Trends:

The global veterinary oncology diagnostics market is expected to reach USD 3.45 billion by 2030, registering a CAGR of 8.4% from 2025 to 2030, according to a new report by Grand View Research, Inc. The market is primarily driven by growing animal population and ownership rates, increased expenditure on animals, shifting focus on preventative animal healthcare, advances in veterinary cancer diagnostic testing, and rising R&D investment in animal health diagnostics to launch innovative products. For instance, in December 2024, Pet Preferred Diagnostics introduced a groundbreaking early cancer diagnostic test for dogs and cats that detects 11 specific onconeural antibodies linked to 21 types of tumors and 14 neurological diseases. This highly sensitive serological test can identify malignancy, often before clinical signs appear, enabling early treatment. It is the only test available in veterinary medicine that differentiates various tumors and neurological conditions, offering a non-invasive, affordable, and quick solution with a 24-hour turnaround.

Additionally, the development of advanced veterinary cancer diagnostic tests, such as the world's first and only at-home cancer screening test by Oncotect, is creating lucrative opportunities in the veterinary oncology diagnostics market. This innovative canine cancer screening test enables early detection, improving treatment outcomes and offering peace of mind to pet owners. Oncotect, which detects the four most prevalent types of canine cancer, can be used at home or in-clinic, making it user-friendly and accessible. The rise in at-home testing solutions, coupled with clinical data supporting its accuracy, is expanding the market for veterinary oncology diagnostics, particularly by increasing accessibility for pet parents.

Furthermore, the increasing prevalence of cancer in pets is significantly driving the growth of the veterinary oncology diagnostics market. As per The Veterinary Cancer Society, Cancer is the top reason of death in 47% of canines, particularly those over 10 years old, and in 32% of felines. Around 1 in 4 dogs will experience abnormal tissue growth, or neoplasia, during their lifetime. With nearly 100 types of cancer affecting pets, a diagnosis can be overwhelming, yet advances in veterinary care have improved treatment success rates for both dogs and cats. Similarly, cancer is the leading cause of death in cats and dogs, affecting one in four dogs and one in five cats in Australia, according to a May 2024 study by the Australian Research Data Commons (ARDC). In the U.S., about 6 million pet dogs are expected to be diagnosed with cancer in 2024, creating a unique opportunity to improve cancer diagnosis for both pets and humans, as reported by The Cancer Letter Inc. Additionally, the American Veterinary Association states that one in four dogs will develop neoplasia at some point, and about half of dogs over the age of 10 will develop cancer.

Veterinary Oncology Diagnostics Market Report Highlights:

• By test type, the biopsy segment dominated the market with a share of 32.08% in 2024. However, the genome testing segment is expected to grow at the fastest CAGR of 9.48% during the forecast period due to technological advancements in veterinary cancer diagnostic test kits.
• In terms of animal type, the canine segment attributed to the largest market share in 2024 due to the increase in the dog cancer population and the availability of a huge number of products for canine cancer diagnosis. The feline segment is projected to grow at the fastest rate from 2025 to 2030, owing to the rising population of cats worldwide and the apparent rise in the number of associated diseases.
• In terms of cancer type, the skin cancers segment accounted for the highest market share in 2024 and is expected to grow at the fastest CAGR of 8.56% owing to the rising prevalence of squamous cell carcinoma and skin tumors in cats and dogs.
• By end use, the veterinary hospitals and clinics segment held the highest share of the market in 2024 owing to the increasing demand for diagnostics and readily accessible advanced veterinary cancer diagnostic technologies in hospitals. This segment is estimated to grow at the fastest CAGR in the coming years.
• By region, North America had the largest share, 53.9%, of the market in 2024 and is anticipated to grow the fastest, at 8.6%, in the coming years.
• Advances in innovative liquid biopsy and advanced multi-cancer diagnostic technology have led to the development of more accurate, user-friendly, and cost-effective veterinary oncology diagnostic test kits. Such advancements are expected to drive market growth.

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation and Scope
• 1.2. Research Methodology
• 1.3. Information Procurement
  • 1.3.1. Purchased Database
  • 1.3.2. GVR's Internal Database
  • 1.3.3. Secondary Sources
  • 1.3.4. Primary Research
• 1.4. Information/Data Analysis
• 1.5. Market Formulation & Visualization
• 1.6. Data Validation & Publishing
• 1.7. Model Details
  • 1.7.1. Commodity flow analysis
  • 1.7.2. Global Market: CAGR Calculation
• 1.8. List of Secondary Sources

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
• 2.3. Competitive Insights

Chapter 3. Veterinary Oncology Diagnostics Market Variable Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market
  • 3.1.2. Ancillary Market
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
    • 3.2.1.1. Increasing prevalence of cancer in pets
    • 3.2.1.2. Increasing R&D in veterinary oncolgy diagnostics
    • 3.2.1.3. Growing focus on animal safety
    • 3.2.1.4. Growing uptake of pet insurance
    • 3.2.1.5. Technological advancements in early pet cancer diagnosis
    • 3.2.1.6. Increase in pet population
  • 3.2.2. Market Restraint Analysis
    • 3.2.2.1. High cost of veterinary oncology diagnostics
    • 3.2.2.2. Lack of awareness in developing countries
  • 3.2.3. Market Opportunity Analysis
  • 3.2.4. Market Challenge Analysis
• 3.3. Veterinary Oncology Diagnostics Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Bargaining power of suppliers
    • 3.3.1.2. Bargaining power of buyers
    • 3.3.1.3. Threat of substitution
    • 3.3.1.4. Threat of new entrants
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political & Legal Landscape
    • 3.3.2.2. Economic and Social Landscape
    • 3.3.2.3. Technological landscape
    • 3.3.2.4. Environmental Landscape
  • 3.3.3. Regulatory Framework
  • 3.3.4. Estimated Animal Population, by Key Countries and Key Species, 2018-2024
  • 3.3.5. COVID-19 Impact Analysis

Chapter 4. Veterinary Oncology Diagnostics Market: Animal Type Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. Veterinary Oncology Diagnostics Market Animal Type Movement Analysis
• 4.3. Veterinary Oncology Diagnostics Market Size & Trend Analysis, By Animal Type, 2018 - 2030 (USD Million)
  • 4.3.1. Canine
    • 4.3.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.3.2. Feline
    • 4.3.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.3.3. Others
    • 4.3.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Veterinary Oncology Diagnostics Market: Test Type Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. Veterinary Oncology Diagnostics Market Test Type Movement Analysis
• 5.3. Veterinary Oncology Diagnostics Market Size & Trend Analysis, By Test Type 2018 - 2030 (USD Million)
  • 5.3.1. Blood Tests
    • 5.3.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.3.2. Biopsy
    • 5.3.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.3.3. Genome testing
    • 5.3.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.3.4. Endoscopy
    • 5.3.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.3.5. Urinalysis
    • 5.3.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.3.6. Imaging
    • 5.3.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Veterinary Oncology Diagnostics Market: Cancer Type Estimates & Trend Analysis

• 6.1. Segment Dashboard
• 6.2. Veterinary Oncology Diagnostics Market Cancer Type Movement Analysis
• 6.3. Veterinary Oncology Diagnostics Market Size & Trend Analysis, By Cancer Type, 2018 - 2030 (USD Million)
  • 6.3.1. Lymphoma
    • 6.3.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.3.2. Sarcomas
    • 6.3.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.3.3. Mammary Gland Tumors
    • 6.3.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.3.4. Skin Cancers
    • 6.3.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.3.5. Others
    • 6.3.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Veterinary Oncology Diagnostics Market: End Use Estimates & Trend Analysis

• 7.1. Segment Dashboard
• 7.2. Veterinary Oncology Diagnostics Market End-Use Movement Analysis
• 7.3. Veterinary Oncology Diagnostics Market Size & Trend Analysis, By End-Use 2018 - 2030 (USD Million)
  • 7.3.1. Reference Laboratories
    • 7.3.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.3.2. Veterinary hospitals and clinics
    • 7.3.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. Veterinary Oncology Diagnostics Market: Country Estimates & Trend Analysis

• 8.1. Regional Dashboard
• 8.2. Veterinary Oncology Diagnostics Market Share, By Region, 2023 & 2030, USD Million
• 8.3. Regional Outlook
• 8.4. North America
  • 8.4.1. North America Veterinary Oncology Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.4.2. U.S.
    • 8.4.2.1. Key Country Dynamics
    • 8.4.2.2. Competition Insights
    • 8.4.2.3. U.S. Veterinary Oncology Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million) 8.4.3. Canada
    • 8.4.3.1. Key Country Dynamics
    • 8.4.3.2. Competition Insights
    • 8.4.3.3. Canada Veterinary Oncology Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.4.4. Mexico
    • 8.4.4.1. Key Country Dynamics
    • 8.4.4.2. Competition Insights
    • 8.4.4.3. Mexico Veterinary Oncology Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
• 8.5. Europe
  • 8.5.1. Europe Veterinary Oncology Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.5.2. UK
    • 8.5.2.1. Key Country Dynamics
    • 8.5.2.2. Competition Insights
    • 8.5.2.3. UK Veterinary Oncology Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.5.3. Germany
    • 8.5.3.1. Key Country Dynamics
    • 8.5.3.2. Competition Insights
    • 8.5.3.3. Germany Veterinary Oncology Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.5.4. France
    • 8.5.4.1. Key Country Dynamics
    • 8.5.4.2. Competition Insights
    • 8.5.4.3. France Veterinary Oncology Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.5.5. Italy
    • 8.5.5.1. Key Country Dynamics
    • 8.5.5.2. Competition Insights
    • 8.5.5.3. Italy Veterinary Oncology Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.5.6. Spain
    • 8.5.6.1. Key Country Dynamics
    • 8.5.6.2. Competition Insights
    • 8.5.6.3. Spain Veterinary Oncology Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.5.7. Denmark
    • 8.5.7.1. Key Country Dynamics
    • 8.5.7.2. Competition Insights
    • 8.5.7.3. Denmark Veterinary Oncology Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.5.8. Sweden
    • 8.5.8.1. Key Country Dynamics
    • 8.5.8.2. Competition Insights
    • 8.5.8.3. Sweden Veterinary Oncology Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.5.9. Norway
    • 8.5.9.1. Key Country Dynamics
    • 8.5.9.2. Competition Insights
    • 8.5.9.3. Norway Veterinary Oncology Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
• 8.6. Asia Pacific
  • 8.6.1. Asia Pacific Veterinary Oncology Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.6.2. Japan
    • 8.6.2.1. Key Country Dynamics
    • 8.6.2.2. Competition Insights
    • 8.6.2.3. Japan Veterinary Oncology Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.6.3. China
    • 8.6.3.1. Key Country Dynamics
    • 8.6.3.2. Competition Insights
    • 8.6.3.3. China Veterinary Oncology Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.6.4. India
    • 8.6.4.1. Key Country Dynamics
    • 8.6.4.2. Competition Insights
    • 8.6.4.3. India Veterinary Oncology Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.6.5. Australia
    • 8.6.5.1. Key Country Dynamics
    • 8.6.5.2. Competition Insights
    • 8.6.5.3. Australia Veterinary Oncology Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.6.6. South Korea
    • 8.6.6.1. Key Country Dynamics
    • 8.6.6.2. Competition Insights
    • 8.6.6.3. South Korea Veterinary Oncology Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.6.7. Thailand
    • 8.6.7.1. Key Country Dynamics
    • 8.6.7.2. Competition Insights
    • 8.6.7.3. Thailand Veterinary Oncology Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
• 8.7. Latin America
  • 8.7.1. Latin America Veterinary Oncology Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.7.2. Brazil
    • 8.7.2.1. Key Country Dynamics
    • 8.7.2.2. Competition Insights
    • 8.7.2.3. Brazil Veterinary Oncology Diagnostics Market Estimates And Forecasts, 2018 - 2030
  • 8.7.3. Argentina
    • 8.7.3.1. Key Country Dynamics
    • 8.7.3.2. Competition Insights
    • 8.7.3.3. Argentina Veterinary Oncology Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
• 8.8. Middle East & Africa
  • 8.8.1. Middle East & Africa Veterinary Oncology Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.8.2. South Africa
    • 8.8.2.1. Key Country Dynamics
    • 8.8.2.2. Competition Insights
    • 8.8.2.3. South Africa Veterinary Oncology Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.8.3. Saudi Arabia
    • 8.8.3.1. Key Country Dynamics
    • 8.8.3.2. Competition Insights
    • 8.8.3.3. Saudi Arabia Veterinary Oncology Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.8.4. UAE
    • 8.8.4.1. Key Country Dynamics
    • 8.8.4.2. Competition Insights
    • 8.8.4.3. UAE Veterinary Oncology Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.8.5. Kuwait
    • 8.8.5.1. Key Country Dynamics
    • 8.8.5.2. Competition Insights
    • 8.8.5.3. Kuwait Veterinary Oncology Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)

Chapter 9. Competitive Landscape

• 9.1. Market Participant Categorization
• 9.2. Participants Overview
• 9.3. Financial Performance
• 9.4. Product Benchmarking
• 9.5. Market Position Analysis, 2024 (Heat Map Analysis)
• 9.6. Strategy Mapping
  • 9.6.1. MERGERS AND ACQUISITIONS
  • 9.6.2. LAUNCH
  • 9.6.3. PARTNERSHIPS & COLLABORATIONS
  • 9.6.4. EXPANSION
  • 9.6.5. OTHERS
• 9.7. Company Profiles
  • 9.7.1. Zoetis
    • 9.7.1.1. Participant's overview
    • 9.7.1.2. Financial performance
    • 9.7.1.3. Product Benchmarking
    • 9.7.1.4. Strategic initiatives
  • 9.7.2. Antech Diagnostics, Inc. (Mars Inc.)
    • 9.7.2.1. Participant's overview
    • 9.7.2.2. Financial performance
    • 9.7.2.3. Product Benchmarking
    • 9.7.2.4. Strategic initiatives
  • 9.7.3. IDEXX Laboratories, Inc.
    • 9.7.3.1. Participant's overview
    • 9.7.3.2. Financial performance
    • 9.7.3.3. Product Benchmarking
    • 9.7.3.4. Strategic initiatives
  • 9.7.4. Neogen Corporation
    • 9.7.4.1. Participant's overview
    • 9.7.4.2. Financial performance
    • 9.7.4.3. Product Benchmarking
    • 9.7.4.4. Strategic initiatives
  • 9.7.5. Gold Standard Diagnostics (Eurofins Technologies)
    • 9.7.5.1. Participant's overview
    • 9.7.5.2. Financial performance
    • 9.7.5.3. Product Benchmarking
    • 9.7.5.4. Strategic initiatives
  • 9.7.6. Embark Veterinary, Inc.
    • 9.7.6.1. Participant's overview
    • 9.7.6.2. Financial performance
    • 9.7.6.3. Product Benchmarking
    • 9.7.6.4. Strategic initiatives
  • 9.7.7. VolitionRx Limited
    • 9.7.7.1. Participant's overview
    • 9.7.7.2. Financial performance
    • 9.7.7.3. Product Benchmarking
    • 9.7.7.4. Strategic initiatives
  • 9.7.8. CANCAN DIAGNOSTICS
    • 9.7.8.1. Participant's overview
    • 9.7.8.2. Financial performance
    • 9.7.8.3. Product Benchmarking
    • 9.7.8.4. Strategic initiatives
  • 9.7.9. Oncotect
    • 9.7.9.1. Participant's overview
    • 9.7.9.2. Financial performance
    • 9.7.9.3. Product Benchmarking
    • 9.7.9.4. Strategic initiatives
  • 9.7.10. PetDx
    • 9.7.10.1. Participant's overview
    • 9.7.10.2. Financial performance
    • 9.7.10.3. Product Benchmarking
    • 9.7.10.4. Strategic initiatives
• 9.8. List of Other Market Players

Chapter 10. Key Takeaways